Neoplastic meningitis. Review of a clinical series;Meningitis neoplásica. Revisión de una serie hospitalaria

Neurologia

Volumn 26, Issue 4, 2011, Pages 227-232

  Jimenez Mateos A ^a   Cabrera Naranjo, F ^a   Gonzalez Hernandez A ^a   Fabre Pi, O ^a   Diaz Nicolas S ^a   Lopez Fernandez J C ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Aetiology; Cerebrospinal fluid; Magnetic Resonance Imaging; Meningeal carcinomatosis; Neoplastic meningitis

Indexed keywords

ADOLESCENT; ADULT; AGED; BREAST TUMOR; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CRANIAL NEUROPATHY; DIAGNOSTIC IMAGING; DIPLOPIA; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG TUMOR; NEUROIMAGING; PROGNOSIS; RETROSPECTIVE STUDY; SHORT SURVEY; SOLID TUMOR; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGED; CEREBROSPINAL FLUID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEUKEMIA; MALE; MENINGEAL CARCINOMATOSIS; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79954930837     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2010.07.020     Document Type: Short Survey

References (36)

1. U.S. Department of Health and Human Services. A Profile of Older Americans: 2006. Disponible en: http://www.nicoa.org/PDFs/AoA%20Profile%20of%20Older%20Americans%202006.pdf.[16.02.2008].
2. Edwards B.K., Howe H.L., Ries L.A., Thun M.J., Rosenberg H.M., Yancik R., et al. Annual report to the nation onthe status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002, 94:2766-2792.
3. Yancik R., Ries L.A.G. Cancer in older persons: an international issue in an aging world. Semin Oncol. 2004, 31:128-136.
4. Micheli A., Baili P., Quinn M., Mugno E., Capocaccia R., Grosclaude P. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol. 2003, 14(Suppl.5):v28-v40. EUROCARE Working Group.
5. Ruiz Ovalle J.L., Gil García R., García Rodríguez F.M. Metástasis cerebrales. Resultados de tratamiento y factores pronósticos. Gamo. 2006, 5.
6. Gómez Viera N., Monteagudo Torres M., de Castro Arenas R., Ruiz García D. Complicaciones neurológicas en pacientes con linfomas. Rev Cubana Med. 2000, 39:75-87.
7. Drappatz J., Batchelor T. Leptomeningeal and peripheral nerve metastases. T. Continuum: Lifelong Learning In Neurology. 2005, 11:47-68.
8. Tasdemiroglu E., Kaya A.H., Bek S., Emir C.B., Sengoz A., Kilickesmez O., et al. Neurologic complications of cancer: Part 1: central nervous system metastasis. Neurosurgery Quarterly. 2004, 14:71-83.
9. Eberth C.J. Zur entwicklung des epithelioms (Choleastoms) der pia und der lunge. Arch Path Anat. 1870, 49:51.
10. Sewell RA. Mental Illness Research. Leptomeningeal Carcinomatosis, Education, and Clinical Center (MIRECC) Fellow, Veterans Affairs Connecticut Health Care System, Yale University School of Medicine]. Disponible en: http://emedicine.medscape.com/article/1156338-overview.[30.08.2007].
11. Kaplan J.G., DeSouza T.G., Farkash A., Shafran B., Pack D., Rehman F., et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol. 1990, 9:225-229.
12. Wasserstrom W.R., Glass J.P., Posner J.B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982, 49:759-772.
13. Little J.R., Dale A.J., Okazaki H. Meningeal carcinomatosis: clinical manifestations. Arch Neurol. 1974, 30:138-143.
14. Chamberlain M.C. Neoplastic meningitis. The neurologist. 2006, 12:179-187.
15. Shapiro W.R., Posner J.B., Ushio Y., Chemik N.L., Young D.F. Treatment of meningeal neoplasms. Cancer Treat Rep. 1977, 61:733-743.
16. Nugent J.L., Bunn P.A., Matthews M.J., Ihde J., Cohen M.H., Gazdar A., et al. CNS metastases in small cell bronchogenic carcinoma: increasing frecuency and changing pattern with lengthening survival. Cancer. 1979, 44:1885-1893.
17. Siegal T., Lossos A., Pfeffer M.R. Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology. 1994, 44:1463-1469.
18. Glass J.P., Melamed M., Chernik N.L., Posner J.B. Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology. 1979, 29:1369-1375.
19. van Oostenbrugge R.J., Twijnstra A. Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology. 1999, 53:382-385.
20. Balm M., Hammack J. Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol. 1996, 53:626-632.
21. Sorensen S.C., Eagan R.T., Scott M. Meningeal carcinomatosis in patients with primary breast or lung cancer. Mayo Clin Proc. 1984, 59:91-94.
22. Sáenz S., Conejo-Mir J., Cayuela A. Epidemiología del melanoma en España. Actas Dermosifiliogr. 2005, 96:411-418.
23. Chamberlain M.C. Carcinomatuos meningitis. Arch Neurol. 1997, 54:16-17.
24. Olson M., Chernik N., Posner J. Infiltration of the leptomeninges by systemic cancer, a clinical and pathologic study. Arch Neurol. 1974, 30:122-137.
25. Theodore W.H., Gendelman S. Meningeal carcinomatosis. Arch Neurol. 1981, 38:696-699.
26. Chamberlain M., Corey-Bloom J. Leptomeningeal metastases 111indium-DTPA CSF flow studies. Neurology. 1991, 41:1765-1769.
27. Wolfgang G., Marcus D., Ulrike S. Leptomeningeal carcinomatosis: clinical syndrome in different primaries. J Neuro-oncol. 1998, 38:103-110.
28. Chamberlain MC. Neoplastic meningitis-related encephalopathy: prognostic significance. Neurology. 2003;60:A17-8.
29. Chamberlain M.C. Neoplastic meningitis: a guide to diagnosis and treatment. Curr Opin Neurol. 2000, 13:641-648.
30. Chamberlain M.C. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers. Neurology. 1998, 50:1173-1175.
31. Freilich R.J., Krol G., DeAngelis L.M. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995, 38:51-57.
32. Chamberlain M.C., Sandy A.D., Press G.A. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology. 1990, 403(Pt 1):435-438.
33. Grossman S.A., Krabak M.J. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999, 25:103-119.
34. DeAngelis L.M. Current diagnosis and treatment of leptomeningeal metastasis. J Neurol Oncol. 1998, 38:242-252.
35. Hildebrand J. Prophylaxis and treatment of leptomeningeal carcinomatosis in solid tumors of adulthood. J Neurol Oncol. 1998, 38:193-198.
36. Chamberlain M.C., Johnstoin Sandra K., Glantz Mike J. Neoplastic meningitis-related prognostic significance of the Karnofsky performance status. Arch Neurol. 2009, 66:74-78.